Bryan M. LEWIS,Lawrence Tim FRIEDHOFF,Stephen Clement PISCITELLI,Kunal KISHNANI,Shankar RAMASWAMY,Geetha RAMASWAMY,Melissa RHODES
申请号：
MX2017014192
公开号：
MX2017014192A
申请日:
2016.05.06
申请国别(地区):
MX
年份:
2018
代理人:
摘要：
The present application relates to new uses of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, with other therapeutic agents for the treatment of a neurodegenerative disease.La presente solicitud se refiere a nuevos usos de antagonistas del receptor 5-HT6, específicamente 3- fenilsulfoni1-8-piperazinil -lil-guinolina o sales farmacéuticamente aceptables, hidratos, solvatos, o polimorfos, de la misma, y a la combinación de antagonistas del receptor 5-HT6, específicamente 3-fenilsulfoni1-8-piperazinil-lil-guinolina o sales farmacéuticamente aceptables, hidratos, solvatos, o polimorfos, de la misma, con otros agentes terapéuticos para el tratamiento de una enfermedad neurodegenerativa.
